Synopsys (SNPS) awards CRO Michael Ellow 24,286 restricted stock units

Rhea-AI Filing Summary

Synopsys, Inc. reported that Chief Revenue Officer Michael Ellow received a grant of 24,286 restricted stock units on December 12, 2025. Each unit represents the right to receive one share of Synopsys common stock for no cash payment.

The grant was approved by the Compensation Committee under the Synopsys, Inc. 2006 Employee Equity Incentive Plan. One-sixth of the units vest on June 15, 2026, with the remaining units vesting in five equal semi-annual installments through December 15, 2028, subject to Mr. Ellow’s continued service.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ellow Michael

(Last) (First) (Middle)

675 ALMANOR AVENUE

(Street)

SUNNYVALE CA 94085

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SYNOPSYS INC [ SNPS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Revenue Officer

3. Date of Earliest Transaction (Month/Day/Year)
12/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0.0	12/12/2025		A(1)		24,286		06/15/2026(2)	12/15/2028	Common Stock	24,286	$0.0	24,286	D

Explanation of Responses:

1. The Compensation Committee of the Board of Directors approved a restricted stock unit grant under the Synopsys, Inc. 2006 Employee Equity Incentive Plan.

2. One-sixth (1/6) of the units vest on the date shown followed by five equal semi-annual installments, subject to continued service through each vesting date.

	By: POA pursuant Mary Lai For: Michael Ellow	12/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Synopsys (SNPS) report for Michael Ellow?

Synopsys reported that Chief Revenue Officer Michael Ellow received a grant of 24,286 restricted stock units on December 12, 2025, tied to Synopsys common stock.

How many restricted stock units were granted to Synopsys CRO Michael Ellow?

Chief Revenue Officer Michael Ellow was granted 24,286 restricted stock units, each linked to one share of Synopsys common stock.

When do Michael Ellow’s Synopsys RSUs start vesting and when are they fully vested?

One-sixth of Michael Ellow’s RSUs vest on June 15, 2026. The remaining units vest in five equal semi-annual installments through December 15, 2028, subject to continued service.

Under which equity plan were Michael Ellow’s Synopsys restricted stock units granted?

The RSU grant was approved under the Synopsys, Inc. 2006 Employee Equity Incentive Plan, as authorized by the Compensation Committee of the Board of Directors.

What is the exercise or purchase price for Michael Ellow’s Synopsys restricted stock units?

The restricted stock units have a conversion price of $0.0, meaning no cash payment is required when they convert into Synopsys common stock.

How many derivative securities does Michael Ellow beneficially own after this grant?

Following the reported transaction, Michael Ellow beneficially owns 24,286 restricted stock units as derivative securities, held with direct ownership.